-
-
-
-
-
-
-
Myovant Sciences Ltd. (MYOV) PT Raised to $36 at Evercore ISI, After Submitting NDA
-
-
-
-
-
-
-
Piper Jaffray Starts Otonomy (OTIC) at Overweight
-
-
-
-
-
-
-
Amgen (AMGN): Notes From KOL Call - Piper Jaffray
-
-
-
-
-
-
-
Piper Jaffray Cuts Price Target on NantKwest (NK) to $23; Reiterates Overweight
-
-
-
-
-
-
-
Ignyta (RXDX): Cutting PT to $20 - Piper Jaffray
-
-
-
-
-
-
-
Gilead Sciences (GILD) PT Lowered to $108 at Piper Jaffray
-
-
-
-
-
-
-
Otonomy, Inc. (OTIC) Details The Otiprio Launch; PT to $42 - Piper Jaffray
-
161 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

